Evicenter
P&T meetings

4D-150

Neovascular age-related macular degeneration

Regulatory submission
Not announced
Launch
Not announced
Last updated
180 sources

Product information and disease descriptionProduct descriptionProduct information

Effect of 4D-150 on quality measures

1 evidence topic · 1 source

Medicare quality measure for age-related macular degeneration

“Percentage of patients aged 50 years and older with a diagnosis of age-related macular degeneration (AMD) who had a dilated macular examination performed which included documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage AND the level of macular degeneration severity during one or more office visits within the 12 month performance period” (opens the source at this quote in a new tab)

Effect of 4D-150 on quality measures

No evidence found.